论文部分内容阅读
目的分析研讨硫辛酸联合前列地尔治疗糖尿病周围神经病变的有效性和安全性。方法采用随机抽签方式,从本院2015年4月至2016年7月期间收治的糖尿病周围神经病变疾病者中抽取76例纳入到讨论中,76例患者按入院单双号分38例对照组(前列地尔治疗)和38例研究组(前列地尔+硫辛酸治疗),对比两组患者治疗状况。结果研究组治疗总疗效92.11%比对照组78.95%高,组间数据有统计学意义(P<0.05)。对比两组患者治疗后SNCV、MNCV指数,研究组比对照组优,组间数据有统计学意义(P<0.05)。结论临床治疗糖尿病周围神经病变可考虑将前列地尔和硫辛酸药物联合使用,疗效突出,显著提升神经传导速度,应用性较大。
Objective To investigate the efficacy and safety of lipoic acid combined with alprostadil in the treatment of diabetic peripheral neuropathy. Methods A random sample of 76 patients with diabetic peripheral neuropathy admitted from April 2015 to July 2016 in our hospital was included in the discussion. Alprostadil) and 38 study groups (prostaglandin + lipoic acid) compared the treatment status in both groups. Results The total effective rate of the study group was 92.11% higher than that of the control group 78.95%, with statistical significance (P <0.05). After comparing the SNCV and MNCV index of two groups, the study group was superior to the control group, and the data of the two groups were statistically significant (P <0.05). Conclusion Clinical treatment of diabetic peripheral neuropathy may consider the combination of alprostadil and lipoic acid drugs, the effect is outstanding, significantly enhance the nerve conduction velocity, the applicability of larger.